GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Exam Corner/NGS vs Sanger sequencing

NGS vs Sanger sequencing

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated September 1, 2025

Quick Answer

Certainly! Here's a detailed comparison of **NGS (Next-Generation Sequencing)** and **Sanger Sequencing** in a clear table format: --- ### **NGS vs Sanger Sequencing** | **Feature** | **NGS (Next-Generation Sequencing)** | **Sanger Sequencing** | |----------------------------|------------------------------------------------------------------|---------------------------------------------------------| | **Technology** | Massively parallel sequencing of millions of DNA fragments.


Certainly! Here's a detailed comparison of **NGS (Next-Generation Sequencing)** and **Sanger Sequencing** in a clear table format:

---

### **NGS vs Sanger Sequencing**

| **Feature** | **NGS (Next-Generation Sequencing)** | **Sanger Sequencing** |

|----------------------------|------------------------------------------------------------------|---------------------------------------------------------|

| **Technology** | Massively parallel sequencing of millions of DNA fragments. | Sequencing one DNA fragment at a time. |

| **Throughput** | High throughput – can sequence entire genomes or transcriptomes in one run. | Low throughput – typically sequences a single DNA fragment per reaction. |

| **Speed** | Very fast – can process millions of reads simultaneously. | Slower – requires individual reactions for each fragment. |

| **Cost** | **Lower cost per base** for large-scale projects. | **Higher cost per base** due to lower throughput. |

| **Read Length** | Typically **short reads** (50–300 bp), though long-read technologies (e.g., PacBio, Nanopore) exist. | **Long reads** (up to 1,000 bp or more). |

| **Applications** | Ideal for large-scale projects: whole-genome sequencing (WGS), RNA-seq, metagenomics, targeted panels, etc. | Best for small-scale projects: sequencing single genes, PCR amplicons, or short fragments. |

| **Sensitivity** | Highly sensitive – can detect low-frequency variants and rare mutations. | Less sensitive for detecting rare variants. |

| **Accuracy** | High accuracy due to base-by-base sequencing, but short reads can complicate assembly. | Very high accuracy for individual fragments. |

| **Data Output** | Generates **massive datasets** requiring advanced bioinformatics tools for analysis. | Generates smaller datasets – easier to analyze manually. |

| **Scalability** | Easily scalable for large projects. | Not scalable for high-throughput sequencing. |

| **Workflow** | More complex – involves library preparation, amplification, sequencing, and bioinformatics. | Simpler workflow – PCR amplification followed by sequencing. |

| **Instrumentation** | Requires advanced platforms like Illumina, Ion Torrent, PacBio, or Nanopore. | Uses capillary electrophoresis instruments. |

| **Cost of Setup** | High initial cost for instruments and infrastructure. | Lower initial cost for instruments. |

| **Limitations** | - Short reads (except for long-read platforms). <br> - Requires sophisticated bioinformatics. <br> - Interpretation of variants can be challenging. | - Low throughput. <br> - Expensive for large-scale sequencing. <br> - Limited to shorter fragments. |

---

### **Summary**

  • **NGS** is ideal for **large-scale, high-throughput sequencing** projects, such as whole-genome sequencing, transcriptome profiling, and metagenomics. It is faster, cheaper (per base), and more versatile but requires advanced bioinformatics tools and infrastructure.
  • **Sanger sequencing** remains the gold standard for **small-scale, targeted sequencing** projects due to its simplicity, high accuracy, and ability to generate long reads. However, it is not cost-effective or scalable for large-scale genomic studies.

---

👉 **When to choose NGS vs Sanger sequencing?**

  • Use **NGS** for comprehensive studies requiring massive data output (e.g., genome-wide analysis, RNA-seq, cancer panels).
  • Use **Sanger sequencing** for smaller, targeted tasks (e.g., validating mutations, sequencing single genes, or small PCR amplicons).

Would you like more details on specific applications or workflows for either method? 😊

Related Q&A

Dopamine Beyond Reward. JAMA| May 2026

This review redefines dopamine (DA) signaling beyond its classical role in reward processing, positioning dopaminergic circuits as central regulators of feeding behavior, metabolic sensing, and energy homeostasis. The authors describe how distributed dopamine ensembles across...

Gut–Heart Axis: Gut | May 2026

Introduction Atherosclerosis has traditionally been viewed as a lipid-driven disease. However, emerging evidence highlights a critical role of chronic inflammation and immune activation, with the gut microbiota now recognised as a key modulator of vascular...

Bleeding Risk with Apixaban vs. Rivaroxaban: NEJM March 2026

Clinical Summary In this randomized international trial (COBRRA), investigators compared the bleeding risk of apixaban vs. rivaroxaban in patients with acute venous thromboembolism (VTE), including pulmonary embolism and proximal deep-vein thrombosis. A total of 2,760...

ACG 2025

The American College of Gastroenterology (ACG) 2025 meeting is a prominent annual event where groundbreaking research, clinical studies, and advancements in gastroenterology are presented. At the ACG 2025 meeting, several impactful studies were showcased, providing...

Alcohol Use Disorder (AUD) with Alcohol-Related Liver Disease (ArLD) - Pharmacology

Alcohol Use Disorder (AUD) and Alcohol-Related Liver Disease (ArLD) often coexist, presenting a complex clinical challenge that requires careful consideration of pharmacological treatment. Below is a detailed explanation starting from definitions, the need for pharmacological...

The role of copper dysregulation in Wilson disease

Copper dysregulation plays a central role in the pathogenesis of Wilson disease (WD). The disease arises from the body’s inability to regulate copper levels, leading to its accumulation and subsequent toxicity. Below is a detailed...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer